"We Envision Growth Strategies Most Suited
to Your Business"

Global Defibrillator Market to Reach US$ 14,806.4 Mn by 2026, Medtronic’s Recent FDA Approval to Bode Well for Overall Growth

July 18, 2019 | Healthcare

The Global Defibrillator Market is likely to expand considerably in the coming years due to increasing FDA approvals for the product. According to a report published by Fortune Business Insights, titled “Defibrillator: Global Market Analysis, Insights and Forecast, 2019-2026,” the market was valued at US$ 9,836.8 Mn in 2018. Fortune Business Insights states that the market will be valued at US$ 14,806.4 Mn by 2026, thereby exhibiting a CAGR of 5.3% during the forecast period.

External Defibrillators to be the Most Widely Used Product Type

Among product types, the external defibrillator is likely to emerge as the most widely used product type. The comfort offered by external defibrillators is a major factor that has led to a high demand and high uptake. Additionally, strict government policies regarding installation of external defibrillators in public places has also added to the adoption of these devices. The advantages of an external defibrillator over its counterparts, such as safety with regard to inappropriate shocks and lead poisoning, have led to the rising uptake of external defibrillators. Fortune Business Insights has predicted that the external defibrillators are likely to emerge as the most attractive product type.

North America to Dominate the Global Market

Growing installations of external defibrillators in public places as well as hospitals are likely to drive the defibrillator market in North America. The increasing use of defibrillators in places such as schools, hotels, railway stations, and streets have also aided the growth of the market in North America. Fortune Business Insights states that the defibrillator market in North America was valued at US$ 4,414.1 Mn in 2018. Additionally, the shift in preference towards subcutaneous implanted cardioverter defibrillator (ICD), resulting from growing patient awareness is likely to contribute to the growth of the defibrillator market in North America.

Medtronic Bags FDA Approval for ‘Smart’ Defibrillator

In 2016, Medtronic received clearance from the Food and Drug Administration (FDA) for its ‘smart’ defibrillator.  This was a first of its kind device that was used in patients with irregular heart functioning. The device operated based on algorithms that have been introduced after learning behavioral patterns of the heart. Medtronic’s Claria MRI Quad Cardiac Resynchronization Therapy Defibrillator has the ability to conduct various operations, the major one of which, was its ability to operate inside an MRI machine. The device also contains a processed built-in software that can that can detect the sensitivity of the pulses that are being transferred to the heart. The device also allows the pulse rate and extent to be adjusted through the software. Medtronic’s Claria MRI Quad Cardiac Resynchronization Therapy Defibrillator has a huge impact on the global market and is likely to favor growth of the market in the forthcoming years. Fortune Business Insights further states that with a diverse product portfolio, Medtronic has accounted for a maximum share of the global market.

Some of the leading companies that are operating in the global defibrillator market are Asahi Kasei Corporation, Philips Healthcare, Defibtech, LLC., Cardiac Science, Stryker, CU Medical System Inc., Medtronic Boston Scientific Corporation, Biotronik, LivaNova Plc and Abbott.

Browse Complete Report Details:


The global defibrillator market is segmented based on:

Segmentation of the Global Defibrillator Market

By Type

·    Implantable Cardioverter Defibrillator (ICD)

.    Trans-venous ICD

.    Single Chamber ICD

.    Dual Chamber ICD

.    CRT-D (cardiac resynchronization therapy- defibrillator)

.    Subcutaneous ICD

·    External Defibrillator

.    Automated External Defibrillator (AED)

.    Manual and Semi-Automatic External Defibrillator

.    Wearable External Defibrillator

By End User

·    Hospitals & Clinics

·    Ambulatory, Schools and other Public Places

By Geography

·    North America (USA and Canada)

·    Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)

·    Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)

·    Rest of the World


We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.